Annual ROE
-38.85%
+19.67%+33.61%
December 31, 2023
Summary
- As of February 7, 2025, RXST annual return on equity is -38.85%, with the most recent change of +19.67% (+33.61%) on December 31, 2023.
- During the last 3 years, RXST annual ROE has fallen by -29.58% (-319.09%).
- RXST annual ROE is now -319.09% below its all-time high of -9.27%, reached on December 31, 2020.
Performance
RXST ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-14.78%
+5.24%+26.17%
September 30, 2024
Summary
- As of February 7, 2025, RXST quarterly return on equity is -14.78%, with the most recent change of +5.24% (+26.17%) on September 30, 2024.
- Over the past year, RXST quarterly ROE has increased by +19.26% (+56.58%).
- RXST quarterly ROE is now -124.75% below its all-time high of 59.71%, reached on December 31, 2021.
Performance
RXST Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RXST ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.6% | +56.6% |
| 3 y3 years | -319.1% | +56.6% |
| 5 y5 years | +6.3% | +56.6% |
RXST ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.3% | +33.6% | -124.8% | +93.9% |
| 5 y | 5-year | -319.1% | +33.6% | -124.8% | +93.9% |
| alltime | all time | -319.1% | +33.6% | -124.8% | +93.9% |
RxSight ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -14.78%(-26.2%) |
| Jun 2024 | - | -20.02%(-29.1%) |
| Mar 2024 | - | -28.23%(-17.1%) |
| Dec 2023 | -38.85%(-33.6%) | -34.04%(-19.7%) |
| Sep 2023 | - | -42.37%(-14.7%) |
| Jun 2023 | - | -49.70%(-10.1%) |
| Mar 2023 | - | -55.29%(-7.7%) |
| Dec 2022 | -58.52% | -59.90%(+10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -54.09%(-64.0%) |
| Jun 2022 | - | -150.17%(-37.6%) |
| Mar 2022 | - | -240.57%(-502.9%) |
| Dec 2021 | -35.22%(+279.9%) | 59.71%(+1606.0%) |
| Sep 2021 | - | 3.50%(-129.0%) |
| Jun 2021 | - | -12.05%(-3.1%) |
| Mar 2021 | - | -12.44%(+34.2%) |
| Dec 2020 | -9.27%(-77.6%) | -9.27% |
| Dec 2019 | -41.44% | - |
FAQ
- What is RxSight annual return on equity?
- What is the all time high annual ROE for RxSight?
- What is RxSight annual ROE year-on-year change?
- What is RxSight quarterly return on equity?
- What is the all time high quarterly ROE for RxSight?
- What is RxSight quarterly ROE year-on-year change?
What is RxSight annual return on equity?
The current annual ROE of RXST is -38.85%
What is the all time high annual ROE for RxSight?
RxSight all-time high annual return on equity is -9.27%
What is RxSight annual ROE year-on-year change?
Over the past year, RXST annual return on equity has changed by +19.67% (+33.61%)
What is RxSight quarterly return on equity?
The current quarterly ROE of RXST is -14.78%
What is the all time high quarterly ROE for RxSight?
RxSight all-time high quarterly return on equity is 59.71%
What is RxSight quarterly ROE year-on-year change?
Over the past year, RXST quarterly return on equity has changed by +19.26% (+56.58%)